The medication dramatically reduces food intake, and patients who do not carefully manage their macronutrient composition can develop functional B12 insufficiency even with normal serum levels
While not approved specifically for weight loss, clinical trials showed average weight reduction of 3-5% of body weight, making it the least potent option in this category for weight management
From the selected studies, the following data were extracted: first authors name, publication year, sample size, study location, mean age of participants, intervention (type, dose, and duration of supplementation), study design and end-point values (as means and sd) for the number of follicles, endometrial thickness, TT, progesterone, serum LH levels, serum FSH levels, E2 and SHBG in both intervention and control groups
Its what the industry calls a CDMO a contract development and manufacturing organisation, a company that builds a drug end-to-end for others to sell under their own labels
[57] Nguyen MM, Ahmann FR, Nagle RB, et al
